Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab. Cummings SR, McCulloch C. Osteoporos Int 2020;31:1019-1021.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cummings SR, McCulloch C. Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab. Osteoporos Int 2020;31:1019-1021.
PMID: 32246168